TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference

ANDOVER, Mass., July 28, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in the Canaccord Genuity 46^th Annual Growth Conference in Boston on Tuesday, August 11, 2026. The TransMedics management team will present beginning at 2:00 p.m. ET/ 1:00 p.m. CT